Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in ...

Deep brain stimulation (DBS) is a surgical procedure that entails the delivery of high-frequency electrical impulses to ...

The findings confirm that allosteric inhibition of integrase is clinically viable, validating a new antiviral drug class.

Deciphering how the GR forms oligomers—through the binding of several subunits—opens a crucial avenue for developing more ...

New research suggests that psychedelic drugs may work by strengthening specific brain connections linked to memory and cognition.

Amphista Therapeutics (“the Company” or “Amphista”), a leader in next generation targeted protein degradation (TPD), announced today that it has published data in the journal Nature Communications ...

There has been an endless “war” between pathogen organisms armed with the ability to establish new, genetically based ...

The integration of artificial intelligence (AI) into drug discovery is revolutionizing pharmaceutical research by providing sophisticated tools for understanding and predicting complex biological ...

Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...